G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheimer s disease : report of the NINCDS-ADRDA Work ' Group under the auspices of Department of Health Human Services Task Force on Alzheimer s Disease ', Neurology, vol.34, pp.939-944, 1984.

G. Roman, T. Tatemichi, T. Erkinjuntti, J. Cummings, J. Masdeu et al., Vascular dementia: diagnostic criteria for research studies, Neurology, vol.43, pp.250-260, 1993.

S. Artero, M. Ancelin, F. Portet, A. Dupuy, C. Berr et al., Risk profiles for mild cognitive impairment and progression to dementia are gender specific, J Neurol Neurosurg Psychiatry, vol.79, pp.979-984, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00294905

S. Artero, M. Ancelin, F. Portet, A. Dupuy, C. Berr et al., Risk profiles for mild cognitive impairment and progression to dementia are gender specific, J Neurol Neurosurg Psychiatry, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00294905

B. Winblad, K. Palmer, M. Kivipelto, V. Jelic, L. Fratiglioni et al., Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment, J Intern Med, vol.256, pp.240-246, 2004.

H. Amieva, L. Goff, M. Millet, X. Orgogozo, J. Peres et al., Prodromal Alzheimer s disease: successive ' emergence of the clinical symptoms, Ann Neurol, vol.64, pp.492-498, 2008.

S. Cosentino, Y. Stern, E. Sokolov, N. Scarmeas, J. Manly et al., Plasma ss-amyloid and cognitive decline, Arch Neurol, vol.67, pp.1485-1490, 2010.

N. Graff-radford, J. Crook, J. Lucas, B. Boeve, D. Knopman et al., Association of Low Plasma Abeta42/Abeta40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease, Arch Neurol, vol.64, pp.354-362, 2007.

K. Yaffe, A. Weston, N. Graff-radford, S. Satterfield, E. Simonsick et al., Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline, JAMA, vol.305, pp.261-266, 2011.

C. Jack, . Jr, D. Knopman, W. Jagust, L. Shaw et al., Hypothetical model of dynamic biomarkers of the Alzheimer s pathological cascade, Lancet Neurol, vol.9, pp.119-128, 2010.

J. Lui, S. Laws, Q. Li, V. Villemagne, D. Ames et al., Plasma amyloid-beta as a biomarker in Alzheimer s disease: the AIBL study of aging, J Alzheimers Dis, vol.20, pp.1233-1242, 2010.

H. Fukumoto, M. Tennis, J. Locascio, B. Hyman, J. Growdon et al., Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels, 2003.

L. Bastard, N. Leurs, J. Blomme, W. De, D. Pp et al., Plasma Amyloid-beta Forms in Alzheimer s Disease and Non-Alzheimer s Disease Patients, J Alzheimers Dis, 2010.

A. Koyama, O. Okereke, T. Yang, D. Blacker, D. Selkoe et al., Plasma Amyloid-beta as a Predictor of Dementia and Cognitive Decline: A Systematic Review and Meta-analysis, Arch Neurol, 2012.

R. Mayeux, L. Honig, M. Tang, J. Manly, Y. Stern et al., Plasma A beta 40 and A beta 42 and Alzheimer s disease: relation to age, mortality, Neurology, vol.61, pp.1185-1190, 2003.

N. Pomara, L. Willoughby, J. Sidtis, and P. Mehta, Selective reductions in plasma Abeta 1 42 in healthy elderly subjects during longitudinal follow-up: a ? preliminary report, Am J Geriatr Psychiatry, vol.13, pp.914-917, 2005.

J. Kang, M. Lim, R. Bateman, J. Lee, L. Smyth et al., Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle, Science, vol.326, pp.1005-1007, 2009.

Q. Li, S. Whyte, J. Tanner, G. Evin, K. Beyreuther et al., Secretion of Alzheimer s disease Abeta amyloid peptide by activated human platelets, 1998.